This research study is for people who have newly diagnosed with AL (light chain) amyloidosis and have not yet received any treatment for this condition. The pu…

Amyloid Light-chain Amyloidosis

~Estimated

~$10 – $6,250

Case Comprehensive Cancer CenterNCT07524634

Phase 2

A Phase 2 Clinical Trial of Teclistamab and Daratumumab in Previously Untreated AL Amyloidosis

The purpose of this study is to investigate whether teclistamab-daratumumab combination is effective and safe in AL amyloidosis. The study treatment is divide…

Amyloid Light-chain Amyloidosis

~Estimated

~$10 – $7,500

Rajshekhar Chakraborty, MDNCT07110844